Condition

CIDP clinical trials and research

• 7Clinical trials
• 36Countries

Newest CIDP clinical trials

All recruiting trials (7)

• Real-world efgartigimod use in adults with CIDP

  This study will see if efgartigimod helps adults with CIDP when given as part of routine clinical care.

  Recruiting at 22 sites argenx · Wilmington, North Carolina and 22 other locations · NCT07264426

• Empasiprubart for adults with CIDP

  This study will test whether IV empasiprubart helps improve symptoms and is safe for adults with CIDP, with an initial 24-week randomized comparison to placebo followed by two years of empasiprubart for all participants.

  Recruiting at 94 sites Phase 3 argenx · Birmingham, Alabama and 93 other locations · NCT07091630

• Empasiprubart versus IVIg for treating CIDP in adults

  This trial tests whether empasiprubart works as well as IVIg and is safe for adults with CIDP who currently benefit from IVIg.

  Recruiting at 107 sites Phase 3 argenx · Birmingham, Alabama and 106 other locations · NCT06920004

• Using rituximab to achieve remission in patients with chronic inflammatory demyelinating polyneuropathy

  This study is testing if rituximab can help people with chronic inflammatory demyelinating polyneuropathy feel better and reduce their need for other treatments.

  Recruiting Phase 3 Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) · Amsterdam · NCT06714838

• Comparing IVIG and SCIG dosing for CIDP

  This trial will test whether body composition changes how IVIG and SCIG deliver protective antibodies in adults with CIDP.

  Recruiting Phase 1 Rutgers, The State University of New Jersey · New Brunswick, New Jersey · NCT05584631

• Collecting blood samples from patients undergoing plasma exchange

  This study is collecting blood samples from patients with immune-related diseases who are having plasma exchange to see how their antibody levels change during treatment and to use the samples for future research.

  Recruiting University of Iowa · Iowa City, Iowa · NCT05004493

• Comparing immunoadsorption and immunoglobulins for treating CIDP

  This study is testing whether a new treatment called immunoadsorption works better than immunoglobulin for people with CIDP who haven't improved with other medications.

  Recruiting Phase 2 University of Ulm · Ulm, Baden-Wurttemberg · NCT04881682

Related topics

Quick answers

How many CIDP clinical trials are recruiting right now?

7, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 36 countries. The most sites are in United States (5 trials), Germany (3 trials), Netherlands (3 trials), Argentina (2 trials), Austria (2 trials). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 3: 3, Phase 2: 1, Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →